Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection
- PMID: 6093976
- PMCID: PMC1483675
Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection
Abstract
A new wild-type isolate of Epstein-Barr virus (EBV) was identified in follow-up studies of a case of chronic active EBV infection in an 8-year-old girl who had high titres of antibody to viral capsid antigen and early antigen (EA) (greater than 20 480 and 2560 respectively), persistent splenomegaly and abnormal immunologic features. More than 10 throat washings from this patient failed to transform cord blood lymphocytes (CBL), but at least 7 were able to induce EA in Raji cells. Supernatants from cultures of the lymphoblastoid cell line obtained by in-vitro infection of this patient's leukocytes with the B95-8 strain of EBV revealed a herpesvirus particle when examined by electron microscopy. The same supernatants were unable to transform CBL but could induce EA in Raji cells upon superinfection. In 30 or more trials the patient's lymphocytes never transformed spontaneously but did become positive for EBV nuclear antigen and EA in the first week of culture at least twice. Parallel studies performed on the father of the patient yielded similar results. This, then, is the first report documenting lytic activity associated with a wild-type EBV isolate.
Similar articles
-
Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.J Med Virol. 1999 Jan;57(1):36-46. J Med Virol. 1999. PMID: 9890420
-
Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.Arch Virol. 2004 Jun;149(6):1083-94. doi: 10.1007/s00705-004-0293-z. Epub 2004 Mar 5. Arch Virol. 2004. PMID: 15168196
-
A familial syndrome of susceptibility to chronic active Epstein-Barr virus infection.Can Med Assoc J. 1984 Feb 1;130(3):280-4. Can Med Assoc J. 1984. PMID: 6318944 Free PMC article.
-
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Autoimmunity. 2008. PMID: 18432410 Review.
-
Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.Semin Cancer Biol. 2008 Dec;18(6):409-15. doi: 10.1016/j.semcancer.2008.09.001. Epub 2008 Sep 30. Semin Cancer Biol. 2008. PMID: 18938248 Review.
Cited by
-
Optimal treatment for chronic active Epstein-Barr virus disease.Pediatr Transplant. 2009 Jun;13(4):393-6. doi: 10.1111/j.1399-3046.2008.01095.x. Pediatr Transplant. 2009. PMID: 19032417 Free PMC article. No abstract available.
-
The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice.J Virol. 2005 May;79(10):5971-8. doi: 10.1128/JVI.79.10.5971-5978.2005. J Virol. 2005. PMID: 15857983 Free PMC article.
-
Cytokine Storm Syndromes Associated with Epstein-Barr Virus.Adv Exp Med Biol. 2024;1448:227-248. doi: 10.1007/978-3-031-59815-9_16. Adv Exp Med Biol. 2024. PMID: 39117818 Review.
-
Risk factors in pediatric AIDS.Can Med Assoc J. 1985 Mar 15;132(6):614-5. Can Med Assoc J. 1985. PMID: 2983852 Free PMC article. No abstract available.
-
Progress and problems in understanding and managing primary Epstein-Barr virus infections.Clin Microbiol Rev. 2011 Jan;24(1):193-209. doi: 10.1128/CMR.00044-10. Clin Microbiol Rev. 2011. PMID: 21233512 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous